1. Blogs

Whitney's blog

Las Estancias attracts medical clinics

Albuquerque Journal

In January, 2017, Lovelace Medical Group opened a new clinic in the Las Estancias development of Albuquerque's South Valley. The new location is becoming a hub of economic development in the area, as reported by The Albuquerque Journal's Steve Sinovic. 

Heart Hospital of New Mexico at Lovelace Medical Center implants new WATCHMAN Left Atrial Appendage Closure

Press Release
ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
 
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.
 
People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the left atrial appendage (LAA).

Lovelace Westside Hospital named as Top Place to Work in Healthcare 2017

Press Release
FOR IMMEDIATE RELEASE
 
ALBUQUERQUE – March 3, 2017 – Lovelace Westside Hospital was named to Becker’s Hospital Review’s “150 Top Places to Work in Healthcare 2017” list.
 
The hospital was recognized for encouraging professional development among employees and promoting tomorrow’s leaders.

Lovelace Medical Group clinic recognized as Patient Centered Medical Home

Press Release

FOR IMMEDIATE RELEASE

ALBUQUERQUE – February 27, 2017 – Lovelace Medical Group has announced its largest clinic was recently recognized as a Level 1 Patient-Centered Medical Home (PCMH) by the National Committee for Quality Assurance (NCQA). The recognition puts the Lovelace Medical Group on the map as a beacon of high-quality care and service to patients.

Lovelace Medical Center receives national accreditation in radiation oncology

Press Release
ALBUQUERQUE – February 20, 2017 – Lovelace Medical Center has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR).
 
This accreditation represents the highest level of quality and patient safety in radiation oncology and is awarded only to facilities meeting specific practice guidelines and technical standards.
 
“We are honored to have attained this accreditation in radiation oncology,” said Lovelace Medical Center CEO Tro

Lovelace Health System, UNM Medical Group, Inc., and UNM School of Medicine Announce New Partnership

Press Release

FOR IMMEDIATE RELEASE

ALBUQUERQUE, JANUARY 11, 2017 — Lovelace Health System and UNM Medical Group, Inc., are partnering to deliver enhanced state-of-the-art rehabilitation services to New Mexico patients recovering from health care conditions such as stroke, brain injury and musculoskeletal disorders.

Lovelace Women’s Hospital a Center of Excellence in Robotic Surgery

Press Release
Hospital is first in state to receive COERS designation, signifying world-class safety and quality 
 
Albuquerque, N.M. ─ January , 2017 ─ Lovelace Women’s Hospital has been designated as a Center of Excellence in Robotic Surgery (COERS) by Surgical Review Corporation.

Lovelace Health System earns recognition as New Mexico family-friendly workplace

Press Release
Status will give Lovelace an edge in competition to attract highest-quality applicants
 
(ALBUQUERQUE) – October 26, 2016 - Lovelace Health System earned distinction for its workplace policies by Family Friendly New Mexico, a statewide project developed to recognize companies that have adopted policies that give New Mexico businesses an edge in recruiting and retaining the best employees.
 
“In health care, it is often easy to point out the care that we provide to families as b

Heart Hospital of New Mexico at Lovelace Medical Center implants first-of-its-kind naturally dissolving heart stent in patient with coronary artery disease

Press Release
ALBUQUERQUE, OCTOBER 4, 2016 — Heart Hospital of New Mexico at Lovelace Medical Center today became the first hospital in the state to offer patients with coronary artery disease a new treatment option that literally disappears over time. 
 
The Abbott Absorb bioresorbable vascular scaffold is the world’s first FDA-approved dissolving heart stent. Physicians at Heart Hospital of New Mexico at Lovelace Medical Center today began using the new stent on patients with coronary artery disease, which affects 15 million people in the U.S.